First ophthalmic insert launched

Mydriasert is inserted aseptically using the sterile forceps provided
Mydriasert is inserted aseptically using the sterile forceps provided

Mydriasert (phenylephrine + tropicamide) is a combination of mydriatic agents with a novel method of delivery, indicated for use before surgery or for diagnostic purposes when monotherapy is insufficient. The insert is placed into the conjunctival sac of the affected eye by an appropriately trained healthcare professional.

Compared with eye drops, the insert takes slightly longer to produce mydriasis; however, less nurse intervention may be required and eyesight recovery seems to be more rapid. The insert must be removed 30 minutes after achieving sufficient mydriasis and within 2 hours of insertion.

View Mydriasert drug record

Further Information: Spectrum Thea Pharma

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in